The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 StudySCIRICA, Benjamin M; BHATT, Deepak L; RAZ, Itamar et al.The American heart journal. 2011, Vol 162, Num 5, pp 818-825, issn 0002-8703, 8 p.Article

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes MellitusSCIRICA, Benjamin M; BHATT, Deepak L; CAVENDER, Matthew A et al.The New England journal of medicine. 2013, Vol 369, Num 14, pp 1317-1326, issn 0028-4793, 10 p.Article

Assessment of Hazard Identification Methods for the Automotive DomainTOMER, Fredrik; JOHANNESSEN, Per; OHMAN, Peter et al.Lecture notes in computer science. 2006, pp 247-260, issn 0302-9743, isbn 3-540-45762-3, 1Vol, 14 p.Conference Paper

A technique for fault tolerance assessment of COTS based systemsALEXANDERSSON, Ruben; CHAITANYA, D. Krishna; ÖHMAN, Peter et al.Lecture notes in computer science. 2005, pp 165-178, issn 0302-9743, isbn 3-540-29200-4, 1Vol, 14 p.Conference Paper

Individualized growth hormone substitution with normalized IGF-I levels does not stimulate the renin-angiotensin-aldosterone systemEKMAN, Bertil; ÖHMAN, Peter K; ARNQVIST, Hans J et al.Clinical endocrinology (Oxford. Print). 2002, Vol 57, Num 4, pp 473-479, issn 0300-0664Article

Improved control of automotive software suppliersIVARSSON, Martin; PETTERSSON, Fredrik; ÖHMAN, Peter et al.Lecture notes in computer science. 2005, pp 358-369, issn 0302-9743, isbn 3-540-26200-8, 12 p.Conference Paper

Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA) trialKURLAND, Lisa; MELHUS, Hakan; KARLSSON, Julia et al.American journal of hypertension. 2002, Vol 15, Num 5, pp 389-393, issn 0895-7061Article

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. CommentaryKURLAND, Lisa; MELHUS, Hakan; KUZNETSOVA, Tatiana et al.Journal of hypertension. 2002, Vol 20, Num 4, pp 583-585, issn 0263-6352, 10 p.Article

Tesaglitazar, a Dual PPAR-α/γ Agonist, Hamster Carcinogenicity, Investigative Animal and Clinical StudiesLINDBLOM, Per; BERG, Anna-Lena; SKÄNBERG, Inger et al.Toxicologic pathology. 2012, Vol 40, Num 1, pp 18-32, issn 0192-6233, 15 p.Article